{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:49:18Z","timestamp":1792594158162,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00347-023-01856-y","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:01:46Z","timestamp":1683302506000},"page":"484-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostik des okul\u00e4ren Schleimhautpemphigoids","Diagnostics of ocular mucous membrane pemphigoid"],"prefix":"10.1007","volume":"120","author":[{"given":"Velina","family":"Haralanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","volume":"23","author":"M Ahmed","year":"2004","unstructured":"Ahmed\u00a0M, Zein\u00a0G, Khawaja\u00a0F et\u00a0al (2004) Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 23:579\u2013592","journal-title":"Prog Retin Eye Res"},{"key":"1856_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","volume":"54","author":"KT Amber","year":"2018","unstructured":"Amber\u00a0KT, Murrell\u00a0DF, Schmidt\u00a0E et\u00a0al (2018) Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clinic Rev Allerg Immunol 54:26\u201351","journal-title":"Clinic Rev Allerg Immunol"},{"key":"1856_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1716988","author":"SD Anesi","year":"2020","unstructured":"Anesi SD, Eggenschwiler L, Ferrara M et al (2020) Reliability of conjunctival biopsy for diagnosis of ocular mucous membrane pemphigoid: redetermination of the standard for diagnosis and outcomes of previously biopsy-negative patients. Ocul Immunol Inflamm: 1\u20138. https:\/\/doi.org\/10.1080\/09273948.2020.1716988","journal-title":"Ocul Immunol Inflamm"},{"key":"1856_CR4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0136","author":"NV Beek","year":"2021","unstructured":"Beek NV, Zillikens D, Schmidt E (2021) Bullous autoimmune dermatoses: clinical features, diagnostic evaluation, and treatment options. Dtsch Arztebl Int 118. https:\/\/doi.org\/10.3238\/arztebl.m2021.0136","journal-title":"Dtsch Arztebl Int"},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/ICU.0b013e328302cc61","volume":"19","author":"E Daniel","year":"2008","unstructured":"Daniel\u00a0E, Thorne\u00a0JE (2008) Recent advances in mucous membrane pemphigoid. Curr Opin Ophthalmol 19:292\u2013297","journal-title":"Curr Opin Ophthalmol"},{"key":"1856_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ophtha.2020.07.052","volume":"128","author":"J Dart","year":"2021","unstructured":"Dart\u00a0J, Setterfield\u00a0J, Groves\u00a0RW et al (2021) Autoantibody detection for diagnosis in direct Immunofluorescence-negative mucous membrane pemphigoid: ocular and other sites compared. Ophthalmology 128:372\u2013382","journal-title":"Ophthalmology"},{"key":"1856_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjo.80.4.292","volume":"80","author":"MJ Elder","year":"1996","unstructured":"Elder\u00a0MJ, Bernauer\u00a0W, Leonard\u00a0J et\u00a0al (1996) Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 80:292\u2013296","journal-title":"Br J Ophthalmol"},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/sj.eye.6701385","volume":"18","author":"SK Gibran","year":"2004","unstructured":"Gibran\u00a0SK (2004) Unilateral drug-induced ocular pseudopemphigoid. Eye 18:1270","journal-title":"Eye"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","volume":"142","author":"S Haeberle","year":"2018","unstructured":"Haeberle\u00a0S, Wei\u00a0X, Bieber\u00a0K et al (2018) Regulatory T\u2011cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease. J\u00a0Allergy Clin Immunol 142:1831\u20131842.e7","journal-title":"J Allergy Clin Immunol"},{"key":"1856_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","volume":"10","author":"M Kamaguchi","year":"2019","unstructured":"Kamaguchi\u00a0M, Iwata\u00a0H (2019) The diagnosis and blistering mechanisms of mucous membrane pemphigoid. Front Immunol 10:34","journal-title":"Front Immunol"},{"key":"1856_CR11","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1111\/bjd.15925","volume":"178","author":"M Kamaguchi","year":"2018","unstructured":"Kamaguchi\u00a0M, Iwata\u00a0H, Ujiie\u00a0H et\u00a0al (2018) Oral mucosa is a\u00a0useful substrate for detecting autoantibodies of mucous membrane pemphigoid. Br J Dermatol 178:e119\u2013e121","journal-title":"Br J Dermatol"},{"key":"1856_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/08820538.2011.588660","volume":"26","author":"M Kirzhner","year":"2011","unstructured":"Kirzhner\u00a0M, Jakobiec\u00a0FA (2011) Ocular cicatricial pemphigoid: a\u00a0review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol 26:270\u2013277","journal-title":"Semin Ophthalmol"},{"key":"1856_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajo.2017.08.009","volume":"183","author":"MT Labowsky","year":"2017","unstructured":"Labowsky\u00a0MT, Stinnett\u00a0SS, Liss\u00a0J et\u00a0al (2017) Clinical implications of direct immunofluorescence findings in patients with ocular mucous membrane pemphigoid. Am J Ophthalmol 183:48\u201355","journal-title":"Am J Ophthalmol"},{"key":"1856_CR14","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.2147\/OPTH.S388886","volume":"16","author":"G Li","year":"2022","unstructured":"Li\u00a0G, Akpek\u00a0EK, Ahmad\u00a0S (2022) Glaucoma and ocular surface disease: more than meets the eye. Clin Ophthalmol 16:3641\u20133649","journal-title":"Clin Ophthalmol"},{"key":"1856_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1684\/ejd.2016.2772","volume":"26","author":"X Li","year":"2016","unstructured":"Li\u00a0X, Qian\u00a0H, Sogame\u00a0R et\u00a0al (2016) Integrin \u03b24 is a\u00a0major target antigen in pure ocular mucous membrane pemphigoid. Eur J Dermatol 26:247\u2013253","journal-title":"Eur J Dermatol"},{"key":"1856_CR16","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/bjd.17694","volume":"180","author":"R Maglie","year":"2019","unstructured":"Maglie\u00a0R, Borgi\u00a0A, Caproni\u00a0M et\u00a0al (2019) Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used? Br J Dermatol 180:1266\u20131267","journal-title":"Br J Dermatol"},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1111\/jdv.18617","volume":"37","author":"R Maglie","year":"2023","unstructured":"Maglie\u00a0R, De Almeida\u00a0CV, Baffa\u00a0ME et al (2023) Anti-\u03b24 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a\u00a0tertiary centre in Italy. J\u00a0Eur Acad Dermatol Venereol 37:e249\u2013e251","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1856_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0031-1299403","volume":"229","author":"E Mameletzi","year":"2012","unstructured":"Mameletzi\u00a0E, Hamedani\u00a0M, Majo\u00a0F et\u00a0al (2012) Clinical manifestations of mucous membrane pemphigoid in a\u00a0tertiary center. Klin Monatsbl Augenheilkd 229:416\u2013419","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1856_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ophtha.2017.10.004","volume":"125","author":"HS Ong","year":"2018","unstructured":"Ong\u00a0HS, Setterfield\u00a0JF, Minassian\u00a0DC et\u00a0al (2018) Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and its relationship to direct Immunofluorescence findings. Ophthalmology 125:496\u2013504","journal-title":"Ophthalmology"},{"key":"1856_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0002-9394(76)90433-5","volume":"82","author":"JT Patten","year":"1976","unstructured":"Patten\u00a0JT, Cavanagh\u00a0HD, Allansmith\u00a0MR (1976) Induced ocular pseudopemphigoid. Am J Ophthalmol 82:272\u2013276","journal-title":"Am J Ophthalmol"},{"key":"1856_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-60399-4","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"U Pleyer","year":"2021","unstructured":"Pleyer\u00a0U (2021) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin Heidelberg"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","volume":"35","author":"H Rashid","year":"2021","unstructured":"Rashid\u00a0H, Lamberts\u00a0A, Borradori\u00a0L et\u00a0al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology\u2014Part I. J\u00a0Eur Acad Dermatol Venereol 35:1750\u20131764","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1856_CR23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1055\/s-0032-1328748","volume":"230","author":"A R\u00fcbsam","year":"2013","unstructured":"R\u00fcbsam\u00a0A, Klein\u00a0JP, Pleyer\u00a0U (2013) Ocular cicatricial pemphigoid\u2014state of the art in clinic and therapy for a\u00a0problematic disease. Klin Monatsbl Augenheilkd 230:796\u2013803","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1856_CR24","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","volume":"35","author":"E Schmidt","year":"2021","unstructured":"Schmidt\u00a0E, Rashid\u00a0H, Marzano\u00a0AV et\u00a0al (2021) European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology\u2014Part II. J\u00a0Eur Acad Dermatol Venereol 35:1926\u20131948","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","volume":"145","author":"E Schmidt","year":"2001","unstructured":"Schmidt\u00a0E, Skrobek\u00a0C, Kromminga\u00a0A et al (2001) Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 145:778\u2013783","journal-title":"Br J Dermatol"},{"key":"1856_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1365-2133.1999.02763.x","volume":"140","author":"J Setterfield","year":"1999","unstructured":"Setterfield\u00a0J, Shirlaw\u00a0PJ, Bhogal\u00a0BS et\u00a0al (1999) Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 140:645\u2013650","journal-title":"Br J Dermatol"},{"key":"1856_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101461","author":"L Shi","year":"2022","unstructured":"Shi L, Li X, Qian H (2022) Anti-Laminin 332-type mucous membrane pemphigoid. Biomolecules 12. https:\/\/doi.org\/10.3390\/biom12101461","journal-title":"Biomolecules"},{"key":"1856_CR28","first-page":"864","volume":"19","author":"F Solimani","year":"2021","unstructured":"Solimani\u00a0F, Forchhammer\u00a0S, Schloegl\u00a0A et\u00a0al (2021) J\u00a0Dtsch Dermatol Ges 19:864\u2013883","journal-title":"J Dtsch Dermatol Ges"},{"key":"1856_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0161-6420(89)32942-3","volume":"96","author":"J Tauber","year":"1989","unstructured":"Tauber\u00a0J, Melamed\u00a0S, Foster\u00a0CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33\u201337","journal-title":"Ophthalmology"},{"key":"1856_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","volume":"111","author":"JE Thorne","year":"2004","unstructured":"Thorne\u00a0JE, Anhalt\u00a0GJ, Jabs\u00a0DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45\u201352","journal-title":"Ophthalmology"},{"key":"1856_CR31","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/eye.2011.175","volume":"25","author":"GP Williams","year":"2011","unstructured":"Williams\u00a0GP, Radford\u00a0C, Nightingale\u00a0P et\u00a0al (2011) Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom. Eye 25:1207\u20131218","journal-title":"Eye"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01856-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01856-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01856-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T16:15:00Z","timestamp":1683908100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01856-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01856-y","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"4 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0Haralanova, und K.\u00a0Meier geben an, dass kein Interessenkonflikt besteht. U.\u00a0Pleyer Interessenkonflikte liegen bei Springer vor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}